ProBioGen AG


ProBioGen is a specialist service and technology provider for cell line development and manufacturing
of complex therapeutic proteins and viral vaccines. 

Combining both state-of-the-art development platforms and intelligent product-specific technologies (such as GlymaxX® for ADCC enhancement of mAbs or our DirectedLuck Transposase for significant titer increase),
we produce your biologics at highest quality with optimized characteristics. Rapid and integrated cell line and process development, comprehensive analytical development and following robust GMP manufacturing is performed by a highly skilled and experienced team. 

All services and technologies are embedded in a quality management system to assure compliance with international ISO and GMP standards (EMA/FDA). 

In 2019, ProBioGen has opened its second manufacturing facility in Berlin, offering GMP Manufacturing
up to 1000L scale.